Related Experiment Video
Updated: Jan 5, 2026

Author Spotlight: Advancements in Understanding and Combatting Shigella Infections
Published on: February 9, 2024
Shigella: Antibiotic-Resistance Mechanisms And New Horizons For Treatment
Reza Ranjbar1, Abbas Farahani1
1Molecular Biology Research Center, Systems Biology and Poisonings Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Abstract:
Shigella spp. are a common cause of diarrheal disease and have remained an important pathogen responsible for increased rates of morbidity and mortality caused by dysentery each year around the globe. Antibiotic treatment of Shigella infections plays an essential role in reducing prevalence and death rates of the disease. However, treatment of these infections remains a challenge, due to the global rise in broad-spectrum resistance to many antibiotics. Drug resistance in Shigella spp. can result from many mechanisms, such as decrease in cellular permeability, extrusion of drugs by active efflux pumps, and overexpression of drug-modifying and -inactivating enzymes or target modification by mutation. Therefore, there is an increasing need for identification and evolution of alternative therapeutic strategies presenting innovative avenues against Shigella infections, as well as paying further attention to this infection. The current review focuses on various antibiotic-resistance mechanisms of Shigella spp. with a particular emphasis on epidemiology and new mechanisms of resistance and their acquisition, and also discusses the status of novel strategies for treatment of Shigella infection and vaccine candidates currently under evaluation in preclinical or clinical phases.
Insights
Shigella bacteria cause severe dysentery globally. Rising antibiotic resistance necessitates exploring new treatments and vaccines against Shigella infections.
Area of Science:
- Microbiology and Infectious Diseases
- Antimicrobial Resistance
- Drug Discovery
Background:
- Shigella spp. are a major cause of global morbidity and mortality due to dysentery.
- Antibiotic therapy is crucial for managing Shigella infections but is increasingly challenged by widespread antibiotic resistance.
- Mechanisms of resistance include reduced permeability, active efflux pumps, enzyme activity, and target modification.
Purpose of the Study:
- To review antibiotic resistance mechanisms in Shigella spp.
- To emphasize the epidemiology and novel resistance acquisition pathways.
- To discuss emerging therapeutic strategies and vaccine candidates for Shigella infections.
Main Methods:
- Literature review of antibiotic resistance mechanisms in Shigella.
- Analysis of epidemiological data on Shigella infections and resistance.
- Evaluation of current preclinical and clinical research on novel treatments and vaccines.
Main Results:
- Detailed overview of diverse antibiotic resistance mechanisms in Shigella.
- Highlighting the increasing prevalence and spread of drug-resistant strains.
- Identification of promising novel therapeutic approaches and vaccine candidates.
Conclusions:
- Urgent need for alternative strategies to combat multidrug-resistant Shigella.
- Continued research into resistance mechanisms and novel interventions is critical.
- Development of effective vaccines and treatments is essential for controlling Shigella infections.
Related Concept Videos
Development of Antibiotic Resistance
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Antibiotic Selection
Gene Regulation in Microbial Communities: Quorum Sensing
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Combined Effects of Drugs: Synergism
Such synergistic combinations...

